Literature DB >> 2723274

Hemodynamic benefit of atrioventricular synchrony: prediction from baseline Doppler-echocardiographic variables.

A C Pearson1, D L Janosik, R M Redd, T A Buckingham, A J Labovitz.   

Abstract

The purpose of this study was to determine if baseline Doppler-echocardiographic variables of systolic or diastolic function could predict the hemodynamic benefit of atrioventricular (AV) synchronous pacing. Twenty-four patients with a dual chamber pacemaker were studied. Baseline M-mode and two-dimensional echocardiograms were obtained and Doppler-echocardiographic measurements of mitral inflow and left ventricular outflow were made in VVI mode (single rate demand) and in VDD (atrial synchronous, ventricular inhibited) and DVI (AV sequentially paced) modes at AV intervals ranging from 50 to 300 ms. Forward stroke volume and cardiac output were determined in each mode at each AV interval from the left ventricular outflow tract flow velocities, and the percent increase in cardiac output over VVI mode was determined. M-mode measurements, including left ventricular end-diastolic dimension, shortening fraction and left atrial size and Doppler measurement of diastolic filling, including peak early velocity and percent atrial contribution, did not correlate with the percent increase in cardiac output during physiologic pacing. The stroke volume in VVI mode correlated significantly with the percent increase in cardiac output during physiologic pacing (r = -0.61, p less than 0.005 for VDD mode and r = -0.55, p less than 0.05 for DVI mode). Five of the 15 patients with VVI stroke volume less than 50 ml but none of the 9 patients with stroke volume greater than 50 ml had ventriculoatrial (VA) conduction.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1989        PMID: 2723274     DOI: 10.1016/0735-1097(89)90356-2

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  8 in total

1.  Comparison of echocardiography and device based algorithm for atrio-ventricular delay optimization in heart block patients.

Authors:  Rajesh Vijayvergiya; Ankur Gupta
Journal:  World J Cardiol       Date:  2015-11-26

2.  Intraoperative rhythm analysis using pulmonary venous Doppler: importance of atrioventricular interval.

Authors:  M D Brown; P C Frommelt
Journal:  Pediatr Cardiol       Date:  2006 Jan-Feb       Impact factor: 1.655

3.  Difference in mechanical atrioventricular delay between atrial sensing and atrial pacing modes in patients with hypertrophic and dilated cardiomyopathy: an electrical hemodynamic catheterization study.

Authors:  Yong-Mei Cha; Rick A Nishimura; David L Hayes
Journal:  J Interv Card Electrophysiol       Date:  2002-06       Impact factor: 1.900

4.  "Subclinical" pacemaker syndrome: a randomised study of symptom free patients with ventricular demand (VVI) pacemakers upgraded to dual chamber devices.

Authors:  N Sulke; A Dritsas; J Bostock; A Wells; R Morris; E Sowton
Journal:  Br Heart J       Date:  1992-01

5.  Assessment of the optimal atrioventricular delay in dual chamber-paced patients by a portable scintillation probe (VEST).

Authors:  L Mortelmans; W Vanhecke; D Mertens; H Ector; C Timmermans; M De Roo; H De Geest; F Van de Werf
Journal:  J Nucl Cardiol       Date:  1996 Jul-Aug       Impact factor: 5.952

6.  Single-chamber versus dual-chamber implantable cardioverter defibrillators: do we need physiologic pacing in the course?

Authors:  Marco Budeus; Thomas Buck; Heinrich Wieneke; Raimund Erbel; Stefan Sack
Journal:  Indian Pacing Electrophysiol J       Date:  2006-07-01

7.  Echocardiographic AV-interval optimization in patients with reduced left ventricular function.

Authors:  C Melzer; A C Borges; F Knebel; W S Richter; W Combs; G Baumann; H Theres
Journal:  Cardiovasc Ultrasound       Date:  2004-12-17       Impact factor: 2.062

Review 8.  Dual chamber versus single chamber ventricular pacemakers for sick sinus syndrome and atrioventricular block.

Authors:  J Dretzke; W D Toff; G Y H Lip; J Raftery; A Fry-Smith; R Taylor
Journal:  Cochrane Database Syst Rev       Date:  2004
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.